Scientific medical research

Welcome to Myrexis Inc

Welcome to Myrexis, Inc.

Myrexis, Inc. is a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and distinct mechanisms of action. The Company has generated a strong pipeline of differentiated product candidates in oncology and autoimmune diseases. Myrexis is focused on maximizing the therapeutic and commercial value of these molecules by developing potential first-in-class and/or best-in-class treatment options for patients with unmet needs.

Our lead product candidates include:

On February 15, 2012 the Company announced that it has retained Stifel Nicolaus Weisel, an investment banking firm, to assist it in evaluating a full range of strategic alternatives available to the Company. The Company continues to actively pursue business development opportunities for each of its programs.

If you are interested in learning more about our development candidates or collaborating with Myrexis, Inc., please contact our Business Development group:

Gradon Knotts
VP, Business Development
business.development@myrexis.com